Wixela Inhub Alternatives Compared
| Wixela Inhub (fluticasone / salmeterol) | Dupixent (dupilumab) | Advair Diskus (fluticasone / salmeterol) |
|
|---|
| Wixela Inhub (fluticasone / salmeterol) | Dupixent (dupilumab) | Advair Diskus (fluticasone / salmeterol) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Asthma - Maintenance. Wixela Inhub may also be used for purposes not listed in this medication guide. |
Prescription only
Dupixent injection is usually given every 1 to 4 weeks to treat asthma, eczema, chronic rhinosinusitis, COPD, eosinophilic esophagitis, or prurigo nodularis. Injection site reactions and eye problems... View more |
Prescription only
Prescribed for Asthma - Maintenance, COPD - Maintenance. Advair Diskus may also be used for purposes not listed in this medication guide. |
Related suggestions Asthma, Maintenance
|
|||||||||||||||||||||||
| More about Wixela Inhub (fluticasone / salmeterol) | More about Dupixent (dupilumab) | More about Advair Diskus (fluticasone / salmeterol) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Wixela Inhub has an average rating of 2.2 out of 10 from a total of 117 ratings on Drugs.com. 11% of reviewers reported a positive effect, while 84% reported a negative effect. |
Dupixent has an average rating of 7.1 out of 10 from a total of 477 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 21% reported a negative effect. |
Advair Diskus has an average rating of 7.2 out of 10 from a total of 113 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 19% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
| Lower cost generic approved |
N/A |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Wixela Inhub prices |
View all Dupixent prices |
View all Advair Diskus prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other fluticasone / salmeterol brands include: Advair Diskus, Advair HFA, AirDuo Respiclick |
N/A |
Other fluticasone / salmeterol brands include: Advair HFA, AirDuo Respiclick, Wixela Inhub | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
12.6 hours |
N/A |
12.6 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 463 drugs are known to interact with Wixela Inhub:
|
A total of 88 drugs are known to interact with Dupixent:
|
A total of 463 drugs are known to interact with Advair Diskus:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
March 28, 2017 |
August 24, 2000 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.